1
|
Chen ZG, Meng P, Li HT, Li M, Yang LF, Yan Y, Li YT, Zou XL, Wang DY, Zhang TT. Thymic stromal lymphopoietin contribution to the recruitment of circulating fibrocytes to the lung in a mouse model of chronic allergic asthma. J Asthma 2017; 55:975-983. [PMID: 28972433 DOI: 10.1080/02770903.2017.1386213] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
Objective: Fibrocyte localization to the airways and thymic stromal lymphopoietin (TSLP) overexpression in the lung are features of severe asthma. The aim of this study was to determine whether TSLP contributes to fibrocyte trafficking and airway remodeling in a mouse model of allergic asthma. Methods: We established a chronic asthma animal model by administering house dust mite (HDM) extracts intranasally for up to 5 consecutive weeks. Mouse anti-TSLP monoclonal antibody (mAb) was given intraperitoneally starting the 4th week. Fluorescence-labeled CD34/collagen I (Col I)-dual-positive fibrocytes were examined by confocal microscopy. The level of TGF-β1 in the bronchoalveolar lavage (BAL) fluid was determined by ELISA. Results: We found significantly increased levels of TSLP and TGF-β1 in the lung of the mice subjected to repeated allergen exposure, which was accompanied by increased number of fibrocytes in the sub-epithelial zone and the BAL fluid. However, blocking TSLP markedly decreased the production of TGF-β1, reduced the number of fibrocytes and subsequently prevented alterations of both airway and vascular structures. Conclusions: Our data suggested that TSLP might function in airway remodeling by promoting circulating fibrocyte recruitment to the lung in the mice subjected to chronic allergen exposure. These results provide a better rationale for targeting the interaction between TSLP and fibrocytes as a therapeutic approach for chronic allergic asthma.
Collapse
Affiliation(s)
- Zhuang-Gui Chen
- a Department of Pulmonary Diseases, The Third Affiliated Hospital of Sun Yat-Sen University , Institute of Respiratory Diseases of Sun Yat-Sen University , Guangzhou , China.,b Department of Pediatrics , The Third Affiliated Hospital of Sun Yat-Sen University , Guangzhou , China
| | - Ping Meng
- a Department of Pulmonary Diseases, The Third Affiliated Hospital of Sun Yat-Sen University , Institute of Respiratory Diseases of Sun Yat-Sen University , Guangzhou , China
| | - Hong-Tao Li
- a Department of Pulmonary Diseases, The Third Affiliated Hospital of Sun Yat-Sen University , Institute of Respiratory Diseases of Sun Yat-Sen University , Guangzhou , China
| | - Ming Li
- c Department of Pulmonary Diseases, The First Affiliated Hospital of Sun Yat-Sen University , Institute of Respiratory Diseases of Sun Yat-Sen University , Guangzhou , China
| | - Li-Fen Yang
- b Department of Pediatrics , The Third Affiliated Hospital of Sun Yat-Sen University , Guangzhou , China
| | - Yan Yan
- d Department of Otolaryngology, Yong Loo Lin School of Medicine , National University of Singapore , Singapore
| | - Ya-Ting Li
- b Department of Pediatrics , The Third Affiliated Hospital of Sun Yat-Sen University , Guangzhou , China
| | - Xiao-Ling Zou
- a Department of Pulmonary Diseases, The Third Affiliated Hospital of Sun Yat-Sen University , Institute of Respiratory Diseases of Sun Yat-Sen University , Guangzhou , China
| | - De-Yun Wang
- d Department of Otolaryngology, Yong Loo Lin School of Medicine , National University of Singapore , Singapore
| | - Tian-Tuo Zhang
- a Department of Pulmonary Diseases, The Third Affiliated Hospital of Sun Yat-Sen University , Institute of Respiratory Diseases of Sun Yat-Sen University , Guangzhou , China
| |
Collapse
|
2
|
Glazer ES, Welsh E, Pimiento JM, Teer JK, Malafa MP. TGFβ1 overexpression is associated with improved survival and low tumor cell proliferation in patients with early-stage pancreatic ductal adenocarcinoma. Oncotarget 2017; 8:999-1006. [PMID: 27895310 PMCID: PMC5352213 DOI: 10.18632/oncotarget.13533] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2016] [Accepted: 09/16/2016] [Indexed: 12/13/2022] Open
Abstract
The role of transforming growth factor beta-type-1 (TGFβ1) in pancreatic ductal adenocarcinoma (PDAC) progression is stage-dependent. We hypothesized that TGFβ1 expression is associated with survival and proliferation markers in patients with early-stage PDAC. We acquired clinicopathologic, treatment, and mRNA expression data from The Cancer Genome Atlas data set for 106 patients identified with stage I/II PDAC who underwent pancreaticoduodenectomy. Patients were categorized as high expression when mRNA expression was ≥75th percentile for each gene. Average log2 mRNA expression of TGFβ1 in patients with high expression was 11.6 ± 0.2 and 10.5 ± 0.6 in patients with low expression (P<0.001). Low TGFβ1 expression is associated with shorter median survival compared with high TGFβ1 expression (17 versus at least 60 months; P=0.005). Patients with tumors demonstrating high MKI67 (the gene encoding Ki-67) expression have shorter median survival versus those with lowerMKI67 expression (16 versus 20 months; P=0.026). TGFβ1 and MKI67 are inversely associated (P=0.009). On multivariate analysis, improved survival is associated with TGFβ1 overexpression (P=0.017), adjuvant chemotherapy (P=0.001), and adjuvant radiotherapy (P=0.017), whereas positive surgical margins are associated with worse survival (P=0.002). In patients who undergo pancreaticoduodenectomy for PDAC, high TGFβ1 expression may counteract the worse survival associated with high proliferation.
Collapse
Affiliation(s)
- Evan S. Glazer
- Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
- Department of Surgery, University of Tennessee Health Sciences Center, Memphis, TN, USA
| | - Eric Welsh
- Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
| | - Jose M. Pimiento
- Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
| | - Jamie K. Teer
- Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
| | - Mokenge P. Malafa
- Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
| |
Collapse
|
3
|
Adoptive transfer of fibrocytes enhances splenic T-cell numbers and survival in septic peritonitis. Shock 2014; 40:106-14. [PMID: 23807245 DOI: 10.1097/shk.0b013e31829c3c68] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Fibrocytes are unique, fibroblast-like cells with diverse functions and the potential for immunomodulation, which prompted investigation of their previously unexplored role in sepsis. Specifically, the study goals were to determine if adoptive transfer of fibrocytes would affect outcome in sepsis and to define relevant immunopathologic changes associated with the outcomes. Initial in vitro studies demonstrated that naive T-cell proliferation was significantly increased in cocultures with tissue-derived fibrocytes as compared with culture either alone or with fibroblasts. In vivo, the adoptive transfer of fibrocytes at the time of cecal ligation and puncture significantly improved survival of mice compared with transfer of fibroblasts or saline. Septic mice had lower blood levels of interleukin 6 (IL-6) and markers of organ injury after fibrocyte transfer as well as a reduced bacterial burden. Locally, peritoneal lavage fluid yielded lower bacterial counts, lower IL-6, and reduced inflammatory cell counts when fibrocyte transfer was compared with saline. This was also accompanied by significant increases in splenic CD4(+) and CD8(+) T cells. In vitro stimulation of the splenic T cells demonstrated that, after cecal ligation and puncture and adoptive transfer, the percentages of both CD4(+) and CD8(+) T cells with intracellular interferon γ were increased, whereas those with IL-4 remained similar between the groups. Therefore, it appears the adoptive transfer of fibrocytes improves sepsis survival, lowers bacterial burden, and promotes the proliferation of splenic T cells with a T(H)1 phenotype. These results confirm the immunomodulatory effects of exogenous, tissue-derived fibrocytes in sepsis and suggest their potential in cell therapy.
Collapse
|
4
|
Evidence of a role for fibrocyte and keratinocyte-like cells in the formation of hypertrophic scars. J Burn Care Res 2013; 34:227-31. [PMID: 22955158 DOI: 10.1097/bcr.0b013e318254d1f9] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
Burn injuries affect millions of people every year, and dermal fibrosis is a common complication for the victims. This disfigurement has functional and cosmetic consequences and many research groups have made it the focus of their work to understand the mechanisms that underlie its development. Although significant progress has been made in wound-healing processes, the complexity of events involved makes it very difficult to come up with a single strategy to prevent this devastating fibrotic condition. Inflammation is considered one predisposing factor, although this phase is a necessary aspect of the wound-healing process. Inflammation, driven by infiltrated immune cells, begins minutes after the burn injury and is the prevalent phase of wound healing in the early stages. Accompanying the inflammatory infiltrate, there is evidence that subpopulations of bone marrow-derived cells are also present. These populations include fibrocytes and keratinocyte-like cells, derivatives of CD14 monocytes, a component of the peripheral blood mononuclear cell infiltrate. There is evidence that these cells contribute to regeneration and repair of the wound site, but it is interesting to note that there are also reports that these cells can have adverse effects and may contribute to the development of dermal fibrosis. In this article, the authors present a review of the origin and transdifferentiation of these cells from bone marrow stem cells, the environments that direct this transdifferentiation, and evidence to support their role in fibrosis, as well as potential avenues for therapeutics to control their fibrotic effects.
Collapse
|
5
|
Degen KE, Gourdie RG. Embryonic wound healing: a primer for engineering novel therapies for tissue repair. ACTA ACUST UNITED AC 2013; 96:258-70. [PMID: 23109321 DOI: 10.1002/bdrc.21019] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
Abstract
Scar is the default tissue repair used by the body in response to most injuries-a response that occurs in wounds ranging in seriousness from minor skin cuts to complete severance of the spinal cord. By contrast, before the third trimester of pregnancy embryonic mammals tend to heal without scarring due to a variety of mechanisms and factors that are uniquely in operation during development in utero. The goal of tissue engineering is to develop safe and clinically effective biological substitutes that restore, maintain, or improve tissue function in patients. This review provides a comparative overview of wound healing during development and maturation and seeks to provide a perspective on just how much the embryo may be able teach us in the engineering of new therapies for tissue repair.
Collapse
Affiliation(s)
- Katherine E Degen
- School of Biomedical Engineering Science, Virginia Tech, Blacksburg, USA
| | | |
Collapse
|
6
|
Borie R, Quesnel C, Phin S, Debray MP, Marchal-Somme J, Tiev K, Bonay M, Fabre A, Soler P, Dehoux M, Crestani B. Detection of alveolar fibrocytes in idiopathic pulmonary fibrosis and systemic sclerosis. PLoS One 2013; 8:e53736. [PMID: 23341987 PMCID: PMC3547062 DOI: 10.1371/journal.pone.0053736] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2012] [Accepted: 12/04/2012] [Indexed: 12/22/2022] Open
Abstract
Background Fibrocytes are circulating precursors for fibroblasts. Blood fibrocytes are increased in patients with idiopathic pulmonary fibrosis (IPF). The aim of this study was to determine whether alveolar fibrocytes are detected in broncho-alveolar lavage (BAL), to identify their prognostic value, and their potential association with culture of fibroblasts from BAL. Methods We quantified fibrocytes in BAL from 26 patients with IPF, 9 patients with Systemic Sclerosis(SSc)-interstitial lung disease (ILD), and 11 controls. BAL cells were cultured to isolate alveolar fibroblasts. Results Fibrocytes were detected in BAL in 14/26 IPF (54%) and 5/9 SSc patients (55%), and never in controls. Fibrocytes were in median 2.5% [0.4–19.7] and 3.0% [2.7–3.7] of BAL cells in IPF and SSc-ILD patients respectively. In IPF patients, the number of alveolar fibrocytes was correlated with the number of alveolar macrophages and was associated with a less severe disease but not with a better outcome. Fibroblasts were cultured from BAL in 12/26 IPF (46%), 5/9 SSc-ILD (65%) and never in controls. The detection of BAL fibrocytes did not predict a positive culture of fibroblasts. Conclusion Fibrocytes were detected in BAL fluid in about half of the patients with IPF and SSc-ILD. Their number was associated with less severe disease in IPF patients and did not associate with the capacity to grow fibroblasts from BAL fluid.
Collapse
Affiliation(s)
- Raphael Borie
- Assistance Publique-Hopitaux de Paris, Service de Pneumologie A, Centre de Compétences Maladies Rares Pulmonaires, Hôpital Bichat, Paris, France
- INSERM, Unité 700, Faculté Bichat, Université Paris 7, Paris, France
| | - Christophe Quesnel
- INSERM, Unité 700, Faculté Bichat, Université Paris 7, Paris, France
- Assistance Publique-Hopitaux de Paris, Service d’Anesthésie et de Réanimation Chirurgicale, Hôpital Tenon, Paris, France
| | - Sophie Phin
- INSERM, Unité 700, Faculté Bichat, Université Paris 7, Paris, France
| | - Marie-Pierre Debray
- Assistance Publique-Hopitaux de Paris, Service de Radiologie, Hôpital Bichat, Paris, France
| | | | - Kiet Tiev
- Assistance Publique-Hopitaux de Paris, Service de Médecine Interne, Hôpital Saint Antoine, Paris, France
| | - Marcel Bonay
- INSERM, Unité 700, Faculté Bichat, Université Paris 7, Paris, France
- Assistance Publique-Hopitaux de Paris, Service d'Explorations Fonctionnelles, Hôpital Saint Antoine, Paris, France
- Université Paris Diderot Paris 7, PRES Sorbonne Paris Cité, Paris, France
| | - Aurélie Fabre
- INSERM, Unité 700, Faculté Bichat, Université Paris 7, Paris, France
- Université Paris Diderot Paris 7, PRES Sorbonne Paris Cité, Paris, France
- Assistance Publique-Hopitaux de Paris, Service d'Anatomopathologie, Hôpital Bichat, Paris, France
| | - Paul Soler
- INSERM, Unité 700, Faculté Bichat, Université Paris 7, Paris, France
| | - Monique Dehoux
- INSERM, Unité 700, Faculté Bichat, Université Paris 7, Paris, France
- Assistance Publique-Hopitaux de Paris, Service de Biochimie, Hôpital Bichat, Paris, France
| | - Bruno Crestani
- Assistance Publique-Hopitaux de Paris, Service de Pneumologie A, Centre de Compétences Maladies Rares Pulmonaires, Hôpital Bichat, Paris, France
- INSERM, Unité 700, Faculté Bichat, Université Paris 7, Paris, France
- Université Paris Diderot Paris 7, PRES Sorbonne Paris Cité, Paris, France
- * E-mail:
| |
Collapse
|
7
|
Ren Y, Guo L, Tang X, Apparsundaram S, Kitson C, Deguzman J, Fuentes ME, Coyle L, Majmudar R, Allard J, Truitt T, Hamid R, Chen Y, Qian Y, Budd DC. Comparing the differential effects of LPA on the barrier function of human pulmonary endothelial cells. Microvasc Res 2012; 85:59-67. [PMID: 23084965 DOI: 10.1016/j.mvr.2012.10.004] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2012] [Revised: 10/08/2012] [Accepted: 10/09/2012] [Indexed: 02/08/2023]
Abstract
Lysophosphatidic acid (LPA) is a class of bioactive lyso-phospholipid that mediates most of its biological effects through a family of G protein-coupled receptors of which six have been identified. The role of the LPA pathway in driving chronic lung diseases such as idiopathic pulmonary fibrosis (IPF) has gained considerable academic and industry attention. Modulation of the pulmonary artery endothelial barrier function by the LPA1 receptor has been shown to drive pulmonary fibrosis in murine models of disease. The purpose of this study was (i) to assess the effect of LPA on the barrier function of human pulmonary arterial (HPAEC) and microvascular (HMVEC) endothelial cells and (ii) to identify the LPA receptor subtype(s) responsible for changes in human pulmonary endothelial cell permeability using LPA receptor antagonists and siRNA technology. Analysis of the LPA receptor subtype expression demonstrated predominant expression of LPA2 and LPA6 receptor subtypes in both HPAECs and HMVECs. HPAECs also exhibit low expression of LPA1, LPA3, and LPA4 receptor subtypes. Treatment of cells with increasing concentrations of LPA caused loss of barrier function in HPAECs but not HMVECs, despite both cell types exhibiting very similar LPA receptor expression profiles. The LPA-mediated loss of barrier function in HPAECs appears to be independent of the LPA1 receptor and likely to be mediated via the LPA6 receptor although we cannot exclude an additional role for the LPA2 and LPA4 receptors in mediating these effects. These results suggest cell-specific mechanisms exist in human pulmonary endothelial cells to permit regulation of barrier function downstream of LPA receptors. More importantly, our data indicate that selective LPA1 receptor antagonism may be insufficient for therapeutic use in pulmonary diseases where impaired endothelial barrier function is related to disease initiation and progression.
Collapse
Affiliation(s)
- Yonglin Ren
- Inflammation Discovery Therapeutic Area, Hoffmann-La Roche Inc., Nutley, NJ 07110-1199, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Crawford JR, Haudek SB, Cieslik KA, Trial J, Entman ML. Origin of developmental precursors dictates the pathophysiologic role of cardiac fibroblasts. J Cardiovasc Transl Res 2012; 5:749-59. [PMID: 22972312 DOI: 10.1007/s12265-012-9402-7] [Citation(s) in RCA: 44] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/05/2012] [Accepted: 08/13/2012] [Indexed: 02/06/2023]
Abstract
Fibroblasts in the heart play a critical function in the secretion and modulation of extracellular matrix critical for optimal cellular architecture and mechanical stability required for its mechanical function. Fibroblasts are also intimately involved in both adaptive and nonadaptive responses to cardiac injury. Fibroblasts provide the elaboration of extracellular matrix and, as myofibroblasts, are responsible for cross-linking this matrix to form a mechanically stable scar after myocardial infarction. By contrast, during heart failure, fibroblasts secrete extracellular matrix, which manifests itself as excessive interstitial fibrosis that may mechanically limit cardiac function and distort cardiac architecture (adverse remodeling). This review examines the hypothesis that fibroblasts mediating scar formation and fibroblasts mediating interstitial fibrosis arise from different cellular precursors and in response to different autocoidal signaling cascades. We demonstrate that fibroblasts which generate scars arise from endogenous mesenchymal stem cells, whereas those mediating adverse remodeling are of myeloid origin and represent immunoinflammatory dysregulation.
Collapse
Affiliation(s)
- Jeffrey R Crawford
- Baylor College of Medicine, One Baylor Plaza, M.S. BCM620, Houston TX, 77030, USA
| | | | | | | | | |
Collapse
|
9
|
Naylor MC, Lazar DA, Zamora IJ, Mushin OP, Yu L, Brissett AE, Olutoye OO. Increased in vitro differentiation of fibrocytes from keloid patients is inhibited by serum amyloid P. Wound Repair Regen 2012; 20:277-83. [PMID: 22564223 DOI: 10.1111/j.1524-475x.2012.00782.x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Keloid scarring is a form of fibroproliferative dermal wound healing characterized by growth beyond the confines of the original wound. Fibrocytes, derived from peripheral blood mononuclear cells and inhibited by serum amyloid P (SAP), have been linked to other fibroproliferative diseases. We hypothesized that peripheral blood mononuclear cells of keloid formers have a higher propensity to differentiate into fibrocytes and are more resistant to the effects of SAP. To test this hypothesis, plasma was isolated from peripheral blood samples of keloid (n = 10) and age/sex/race-matched control (n = 10) subjects, and SAP levels were measured by enzyme-linked immunosorbent assay. Equal numbers of peripheral blood mononuclear cells were also isolated from these samples and fibrocytes cultured in serum-free media with increasing concentrations of SAP. No difference in plasma SAP levels was found between keloid and control subjects. In the absence of SAP, keloid patients (n = 7) had almost 20 times more fibrocytes than controls (n = 7) in culture (median: 1,087 cells vs. 60 cells; p < 0.01). SAP inhibited the differentiation of keloid fibrocytes in vitro, although a higher concentration of SAP was needed when compared with controls (20 μg/mL keloid vs. 5 μg/mL control). Fibrocytes may contribute to the pathogenesis of keloids, and SAP has potential as a therapeutic agent in the prevention of these lesions.
Collapse
Affiliation(s)
- Michelle C Naylor
- Bobby R. Alford Department of Otolaryngology-Head & Neck Surgery, Baylor College of Medicine, Houston, TX 77030, USA
| | | | | | | | | | | | | |
Collapse
|
10
|
Lin L, Perets A, Har-el YE, Varma D, Li M, Lazarovici P, Woerdeman DL, Lelkes PI. Alimentary ‘green’ proteins as electrospun scaffolds for skin regenerative engineering. J Tissue Eng Regen Med 2012; 7:994-1008. [DOI: 10.1002/term.1493] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2011] [Revised: 01/20/2012] [Accepted: 01/24/2012] [Indexed: 01/05/2023]
Affiliation(s)
- Leko Lin
- School of Biomedical Engineering, Science and Health Systems; Drexel University; Philadelphia PA USA
| | - Anat Perets
- School of Biomedical Engineering, Science and Health Systems; Drexel University; Philadelphia PA USA
| | - Yah-el Har-el
- School of Biomedical Engineering, Science and Health Systems; Drexel University; Philadelphia PA USA
| | - Devika Varma
- School of Biomedical Engineering, Science and Health Systems; Drexel University; Philadelphia PA USA
| | - Mengyan Li
- School of Biomedical Engineering, Science and Health Systems; Drexel University; Philadelphia PA USA
| | | | | | - Peter I. Lelkes
- School of Biomedical Engineering, Science and Health Systems; Drexel University; Philadelphia PA USA
| |
Collapse
|
11
|
Reprogrammed fibrocytes induce a mixed Th1/Th2 cytokine response of naïve CD4(+) T cells. Mol Cell Biochem 2010; 346:89-94. [PMID: 20922464 DOI: 10.1007/s11010-010-0595-2] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2010] [Accepted: 09/18/2010] [Indexed: 02/02/2023]
Abstract
Naïve CD4(+) T cells develop different effector T cells and cytokine profiles after antigenic stimulation. It has been previously documented that fibrocytes function as antigen presenting cells inducing proliferation as well as Th2 cytokine response in naïve CD4(+) T cells. Our group has reported that several circulating cell types recruited to the wound site can be transformed into anti-fibrotic profile cells, which subsequently induce MMP-1 stimulation in dermal fibroblasts. Here, we report how similar reprogramming pathway of fibrocytes could modify the CD4(+) T cell response. Our findings confirmed that reprogrammed fibrocytes induce CD4(+) T cell activation with a mixed Th1/Th2 cytokine response. Since a reciprocal positive feedback between Th2 cells and fibrocytes exist to amplify and perpetuate the pro-fibrotic stimulation in dermal fibroblasts, the novel transdifferentiation of regular mature fibrocytes into reprogrammed fibrocytes appears to be a promising strategy to reverse the Th2 cytokine overproduction, and subsequently control the local fibrogenesis.
Collapse
|